Pharmaceutical-pharmacological interventions to improve drug therapy safety of inpatient care

Pharmaceutical-pharmacological interventions to improve drug therapy safety of inpatient care - K739

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026088

Enrollment

100

Registered

2021-09-02

Start date

2022-01-13

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

low adherence, problems with drug application/use, patients' concerns regarding their drug therapy

Interventions

Group 1: As part of the screening, patients complete written questionnaires. The individualized intervention follows a semi-structured guideline - depending on the information provided in the question

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients above 18 years of age, who are inpatients on Siebeck ward, are cognitively, linguistically as well as motorically suitable, and have at least completed the screening questionnaires.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Proportion of patients with intervention reporting drug therapy problems during follow-up phone calls compared to patients who had no intervention and complained of drug therapy problems during follow-up phone calls.	—

Secondary

Measure	Time frame
- Type and number of drug therapy problems reported during follow-up calls. - Outcome of the screening questionnaires with regard to a detected need for intervention and possible associations with the actual needs of the patient in the intervention consultation or follow-up phone call - Content and course of the interventions - Analysis of potential associations between screening, identification of a need, course of the intervention and information given in follow-up calls, possibly in relation to other patient characteristics (e.g., age, gender, diagnosis, number and type of drugs, length of hospital stay, other scores collected during routine care). - Proportion of patients reached with the interventions compared to all patients treated on the ward, including evaluation of the group representativeness.	—

Measure

Time frame

- Type and number of drug therapy problems reported during follow-up calls. - Outcome of the screening questionnaires with regard to a detected need for intervention and possible associations with the actual needs of the patient in the intervention consultation or follow-up phone call - Content and course of the interventions - Analysis of potential associations between screening, identification of a need, course of the intervention and information given in follow-up calls, possibly in relation to other patient characteristics (e.g., age, gender, diagnosis, number and type of drugs, length of hospital stay, other scores collected during routine care). - Proportion of patients reached with the interventions compared to all patients treated on the ward, including evaluation of the group representativeness.

—

Countries

Germany

Contacts

Public ContactViktoria Jungreithmayr

Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Kooperationseinheit Klinische Pharmazie

viki.jungreithmayr@med.uni-heidelberg.de+4962215635738

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026